StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research note released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $10.00 price objective on shares of Pulmatrix in a research note on Tuesday, February 7th. Pulmatrix […]
Pulmatrix (NASDAQ:PULM – Get Rating) announced its earnings results on Friday. The biotechnology company reported ($1.22) EPS for the quarter, reports. The business had revenue of $1.50 million during the quarter. Pulmatrix had a negative net margin of 310.26% and a negative return on equity of 51.32%. Pulmatrix Stock Performance PULM traded down $0.14 during […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,300 shares, a drop of 55.2% from the April 15th total of 2,900 shares. Based on an average daily volume of 18,500 shares, the days-to-cover […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) was the target of a large decline in short interest in April. As of April 30th, there was short interest totalling 1,300 shares, a decline of 55.2% from the April 15th total of 2,900 shares. Based on an average trading volume of 18,500 shares, the days-to-cover ratio is currently […]
StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 price target on shares of Pulmatrix in a research report on Tuesday, […]